Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3647513018 | Product containing alpha-4 integrin receptor antagonist (product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3745999012 | Alpha-4 integrin receptor antagonist-containing product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing alpha-4 integrin receptor antagonist | Is a | Product containing selective adhesion molecule inhibitor | true | Inferred relationship | Existential restriction modifier | ||
| Product containing alpha-4 integrin receptor antagonist | Has active ingredient | Substance with alpha-4 integrin receptor antagonist mechanism of action | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing natalizumab | Is a | True | Product containing alpha-4 integrin receptor antagonist | Inferred relationship | Existential restriction modifier | |
| Product containing vedolizumab | Is a | True | Product containing alpha-4 integrin receptor antagonist | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR